CoChat

Progress and Challenges in the Diagnosis of Dementia: A Critical Review

Paraskevaidi, Maria, Martin-Hirsch, Pierre L., Martin, Francis L. · 2018 · ACS Chemical Neuroscience

The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.

Abstract

Longer life expectancies have led to an increased number of neurodegenerative disease cases globally. Accurate diagnosis of this devastating disorder is of crucial importance but is still feasible only by a brain biopsy after death. An enormous amount of attention and research has been in place over the years toward the better understanding of the mechanisms, as well as the early diagnosis, of neurodegeneration. However, numerous studies have been contradictory from time to time, while new diagnostic methods are constantly developed in a tireless effort to tackle the disease. Nonetheless, there is not yet a conclusive report covering a broader range of techniques for the diagnosis of different types of dementia. In this paper, we critically review current knowledge on the different hypotheses about the pathogenesis of distinct types of dementia, as well as risk factors and current diagnostic approaches in a clinical setting, including neuroimaging, cerebrospinal (CSF), and blood tests. Encouraging research results for the diagnosis and investigation of neurodegenerative disorders are also reported. Particular attention is given to the field of spectroscopy as an emerging tool to detect dementias, follow-up patients, and potentially monitor the patients' response to a therapeutic approach. Spectroscopic techniques, such as infrared and Raman spectroscopy, have facilitated numerous disease-related studies, including neurodegenerative disorders, and are currently undergoing trials for clinical implementation. This review constitutes a comprehensive report with an in-depth focus on promising imaging, molecular biomarker and spectroscopic tests in the field of dementive diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acschemneuro.8b00007

Cites

153 of 153 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 153 references

Research works printed but not linked: 5

  1. Kroner Z., 2009, Altern. Med. Rev., 14, 373
  2. Casey D. A., 2010, Pharm. Ther., 35, 208
  3. McKeith I., 2004, Dialogues Clin. Neurosci., 6, 333, 10.31887/dcns.2004.6.3/imckeith · doi:10.31887/dcns.2004.6.3/imckeith
  4. Rohn T. T., 2014, Int. J. Clin. Exp. Pathol., 7, 3504
  5. Paraskevaidi M., 2018, under review

Cited by

See all 32

Metadata

Authors
Paraskevaidi, M., Martin-Hirsch, P. L., & Martin, F. L.
Affiliations
  • University of Lancashire (GB)
  • Department of Obstetrics and Gynaecology, Central Lancashire Teaching Hospitals NHS Foundation Trust, Preston PR2 9HT, United Kingdom
Corresponding author
  • Paraskevaidi, Maria
  • Martin, Francis L.
Venue
ACS Chemical Neuroscience
Published
2018-02-01
Volume
9
Issue
3
Pages
446-461
ISSN
1948-7193 (ISSN-L)
OpenAlex
W2786360376
Cited by
31
References
153
Citations by year
2026: 3 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 7 · 2021: 4 · 2020: 3 · 2019: 5 · 2018: 1
FWCI
0.50
Type
journal article
Language
en
Open access
closed
Locations
  • ACS Chemical Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • CLOK (University of Central Lancashire) (acceptedVersion)
Funders
Rosemere Cancer Foundation
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Spectroscopy Techniques in Biomedical and Chemical Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
dementia diagnosis, neurodegenerative diseases, dementia pathogenesis, risk factors, neuroimaging, cerebrospinal fluid biomarkers, blood biomarkers, infrared spectroscopy, Raman spectroscopy, disease surveillance
MeSH terms
Alzheimer Disease, Animals, Dementia, Humans, Risk, Spectrum Analysis, Raman, Biomarkers, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.